Myrcludex B

DB14853Investigational

Myrcludex B is under investigation in clinical trial NCT03546621 (A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in...

Mechanism: Pharmacologically active on Hepatic sodium/bile acid cotransporter
Curator reviewed

Resolves to

Compound

UNIIJA8K50N04HCAS406461-66-3

Targets

Q14973SLC10A1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Myrcludex B, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account